The data indicate that the expression of CD19+ B-cells was twice as high in the patients with T2DM (17.5%) as in the healthy controls (9.1%) and that the difference was statistically significant (p≤0.001, Figure 2B). Here, CD19 is linked to type 2 diabetes mellitus.